Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate

Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate


    • Product Name Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate
    • Alias EDPC
    • Einecs 412-170-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    832548

    Chemical Formula C10H13NO2
    Molar Mass 179.216 g/mol
    Appearance Solid (predicted)
    Boiling Point 262.6 °C at 760 mmHg (predicted)
    Melting Point 45 - 49 °C
    Density 1.056 g/cm³ (predicted)
    Flash Point 112.6 °C (predicted)
    Water Solubility Insoluble (predicted)
    Logp 2.19 (predicted)
    Pka 15.35±0.20 (predicted)

    As an accredited Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2,4 - Dimethyl - Pyrrole - 3 - Carboxylate packaged in a sealed bottle.
    Shipping Ethyl 2,4 - Dimethyl - Pyrrole - 3 - Carboxylate is shipped in properly sealed containers, following strict chemical transport regulations. Packaging ensures protection from damage and leakage during transit to maintain safety.
    Storage Ethyl 2,4 - Dimethyl - Pyrrole - 3 - Carboxylate should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent moisture and air exposure, which could potentially cause degradation. Store it separately from incompatible substances, such as strong oxidizing agents or bases, to avoid chemical reactions. Ideal storage temperature is around 2 - 8°C in a refrigerator if long - term stability is required.
    Application of Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate

    Substituted Biphenyl Tetrazole Antihypertensives: Intermediate Stability and Coupling Efficiency

    In the synthesis pathway toward sartan-class angiotensin II receptor antagonists (ARBs), ethyl 2,4-dimethyl-pyrrole-3-carboxylate functions as the core pyrrole building block that, following N-alkylation and subsequent Vilsmeier-Haack formylation at the 5-position, undergoes Suzuki-Miyaura cross-coupling with a protected biphenyl tetrazole boronic acid. The ester moiety at C-3 remains intact through the coupling sequence and is hydrolyzed to the free carboxylic acid only at the penultimate step, enabling the generation of candesartan cilexetil prodrug intermediates and related analogues regulated under ICH Q7 Active Pharmaceutical Ingredient GMP guidelines and USP ⟨232⟩/⟨233⟩ elemental impurity limits. Typical stoichiometric loading in the final N-alkylation reaction with 1-chloroethyl cyclohexyl carbonate (for the cilexetil prodrug) operates within a molar ratio of 1.0:1.15 to 1.0:1.30 (pyrrole core to alkylating agent), with excess alkylating agent stripped under vacuum (≤5 mbar, 45–50°C) to levels below 0.1% w/w by GC headspace. Production-scale execution of the Vilsmeier-Haack step in glass-lined reactors (DIN 28136 Pfaudler BE series, 1000–4000 L) requires strict moisture exclusion: DMF used as both solvent and reagent must be dried over 4Å molecular sieves to a water content of ≤100 ppm (Karl Fischer titration, EN 13267:2001), otherwise the phosphoryl chloride complex hydrolyzes exothermically, leading to a drop in formylation yield from a target range of 82–88% to below 40% and generating intractable phosphate residues that foul the rectification column reboiler (Sulzer Mellapak structured packing, 250Y) during downstream high-vacuum distillation of the 5-formyl intermediate. The final deprotection to the carboxylic acid employs aqueous sodium hydroxide (2.0–2.5 M) in a THF/water biphasic system at 50 ± 2°C over 6–8 hours; exceeding 55°C triggers decarboxylation with CO₂ evolution rates exceeding 3.0 L/min in pilot-scale batches, pressurizing the vessel beyond its MAWP rating if the rupture disc (Inconel 625, burst pressure 4.5 barg) is improperly sized. HPLC purity specifications per EP 10.0 monograph for candesartan cilexetil require the crude free acid intermediate to demonstrate relative retention time (RRT) impurity profiles with no single unknown exceeding 0.10% area and total impurities below 0.50% area prior to the final esterification step with the cilexetil moiety.

    When the C-5 Formyl Intermediate Enters a Continuous Hydrogenation Stream

    Beyond the ARB prodrug route, catalytic reduction of the 5-formyl derivative of the pyrrole core opens access to the 5-aminomethyl analogue, a versatile precursor for peptide mimetics and specialized ligand architectures in coordination chemistry. The formyl intermediate—isolated as a pale yellow crystalline solid with a melting point of 92–94°C—is dissolved in anhydrous THF (10 volumes w/v) and subjected to continuous-flow hydrogenation in a ThalesNano H-Cube Pro system equipped with a 30 mm CatCart containing sponge nickel catalyst (Raney Ni type 3111, Grace Davison) at a hydrogen pressure of 60–80 barg and a substrate flow rate of 0.5–1.0 mL/min, maintaining a reactor temperature of 65 ± 3°C. Residence time distribution (RTD) analysis using a step-input tracer method confirms a plug-flow deviation under 8% (D/uL < 0.05), which is critical to preventing over-reduction of the pyrrole ring to the pyrrolidine—a side reaction detected by the disappearance of the characteristic λmax = 258 nm absorbance band in the UV-Vis in-line detector positioned post-reactor. The target application for the 5-aminomethyl intermediate lies in the construction of pyrrole-based NS3 protease inhibitor scaffolds (Hepatitis C therapeutic class), where the primary amine undergoes EDCI/HOBt-mediated amidation with a pyrazinecarboxylic acid derivative in DMF at 0–5°C (jacketed reactor, Lauda Integral XT process thermostat, cooling capacity 2.5 kW at -10°C) to yield a dipeptide isostere. Environmental emission controls for this manufacturing sequence are governed by the EU Industrial Emissions Directive (IED) 2010/75/EU, with particular attention to THF recovery: distillation bottoms from solvent recycling operations must demonstrate peroxide values below 5 mg/kg (titrimetric method per Ph. Eur. 2.5.5) to avoid accumulation of explosive tetrahydrofuran hydroperoxides in the recovery column kettle. The terminal product class comprises orally bioavailable HCV replication complex inhibitors, registered as single-tablet regimen components with viral RNA suppression rates exceeding 99.5% after 12 weeks of therapy; the pyrrole fragment contributes hydrogen-bonding geometry via the carboxamide oxygen and the pyrrole NH, both of which are pharmacophorically mapped onto the S1 pocket of the protease target.

    Transition metal-mediated C-H activation at the unsubstituted 5-position of ethyl 2,4-dimethyl-pyrrole-3-carboxylate enables direct arylation without pre-functionalization by employing a Pd(OAc)₂/PPh₃ catalytic system (5 mol% Pd, 10 mol% PPh₃) with silver carbonate as the halide scavenger (1.5 equivalents) in N,N-dimethylacetamide (DMAc) at 110°C for 18–24 hours. This protocol has been validated at 10 kg scale in a Büchi Glasster 20 L jacketed reactor with overhead mechanical stirring (Heidolph Hei-TORQUE Precision 200), where the exotherm accompanying silver salt addition is moderated by a programmable temperature ramp (0.5°C/min from 25°C to 70°C, followed by a 1.0°C/min ramp to 110°C) to avoid a runaway decomposition of the Ag₂CO₃ that generates CO₂ gas volumes approaching 800 L per batch—a potential overpressurization scenario requiring relief line sizing according to DIERS two-phase flow methodology (ANSI/ASME B31.3). The 5-aryl-pyrrole-3-carboxylate products find downstream utility in the preparation of diarylpyrrole-based COX-2 selective inhibitors where the C-5 aryl substituent (commonly a 4-methylsulfonylphenyl or 4-sulfonamidophenyl group) engages the hydrophobic side pocket of the COX-2 enzyme active site, conferring the >1000-fold selectivity ratio over COX-1 required by FDA guidance MAPP 5016.1 for non-steroidal anti-inflammatory safety profiles. Residual palladium in the isolated intermediate must be controlled to ≤10 ppm (inductively coupled plasma mass spectrometry, USP ⟨232⟩) via treatment with a functionalized silica-bound scavenger (Silicycle SiliaMetS Thiol, 1.0–1.2 mmol/g loading, 5 wt% relative to substrate) at 50°C for 4 hours with overhead agitation at 250 rpm. Final particle size distribution of the crystallized API precursor (D₉₀ ≤ 50 μm, Malvern Mastersizer 3000 with Hydro LV wet dispersion) is achieved through anti-solvent crystallization from acetone/water (60:40 v/v) with a controlled addition rate of 2.0 mL/min, ensuring flowability metrics (Hausner ratio ≤ 1.25, Carr's index ≤ 20%) acceptable for automated drum loading and solid dispensing in secondary manufacturing suites.

    What Determines the Acid Chloride Conversion Threshold in Pyrrole Amidation?

    Saponification of the ethyl ester to the free 2,4-dimethyl-pyrrole-3-carboxylic acid (melting point 187–189°C with decomposition) followed by activation with oxalyl chloride (1.2 equivalents) in dichloromethane containing catalytic DMF (0.05 equivalents) at 0°C yields the acid chloride hydrochloride salt, which is employed directly in amidation reactions with functionalized anilines to produce benzamide derivatives explored as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) for pain management indications. The acid chloride formation must be monitored by ATR-FTIR (ReactIR 15, Mettler Toledo) for the disappearance of the carbonyl stretching band of the acid at 1678 cm⁻¹ and the concomitant rise of the acid chloride band at 1792 cm⁻¹; conversion below 95% after 120 minutes indicates moisture ingress exceeding 50 ppm in the solvent, requiring a nitrogen purge of the solvent reservoir and replacement of the drying column (SICAPENT phosphorus pentoxide on inert carrier, Merck 1.05437) on the solvent delivery line. The amidation step itself is conducted under Schotten-Baumann biphasic conditions: the acid chloride in DCM is added dropwise via a peristaltic pump (Watson-Marlow 530S, flow rate 15 mL/min) to an aqueous solution of the aniline derivative (0.95 equivalents to avoid residual free amine in the organic phase) and potassium carbonate (2.5 equivalents) at 5–10°C, with mixing provided by a rotor-stator high-shear disperser (IKA Ultra-Turrax UTL 1000/10, 8000 rpm) to maintain droplet size distribution with a Sauter mean diameter (D[3,2]) below 50 μm, maximizing interfacial mass transfer and suppressing hydrolysis of the acid chloride back to the acid—a competing pathway that reduces product yield by 1.5–2.0% per each 10°C increment above the setpoint. Isolated benzamide products prepared from this pyrrole acid chloride intermediate are characterized as endocannabinoid system modulators, terminating in therapeutic goods registered under EMA/CHMP/437313/2017 guideline on clinical evaluation of chronic pain therapies. The corresponding plant QC release testing involves chiral HPLC (Chiralpak AD-H, 4.6 × 250 mm, 5 μm) when the benzamide side chain contains a stereogenic center, with enantiomeric excess specified at ≥99.0% and detection wavelength set at 220 nm.

    Coordination of 2,4-dimethyl-pyrrole-3-carboxylic acid—generated via quantitative saponification of the ethyl ester at 80°C in 2.0 M NaOH/methanol (1:1 v/v) for 4 hours—to zinc(II) nitrate hexahydrate in DMF at 100°C under solvothermal autogenous pressure for 48 hours produces a three-dimensional metal-organic framework of sra topology (Reticular Chemistry Structure Resource code sra-dmp-Zn) with BET surface area measured by nitrogen adsorption at 77 K (Quantachrome Autosorb iQ, ISO 9277:2022) of 840 ± 20 m²/g. The water-stable framework maintains crystallinity after 7-day immersion in boiling water, a prerequisite for its functionalization in post-synthetic exchange (PSE) reactions with palladium(II) acetate in acetonitrile, loading 2.8 wt% Pd (as determined by ICP-OES, ISO 11885:2007) homogeneously distributed within the pore channels of diameter 8.5 Å (calculated by NLDFT kernel from the adsorption isotherm). This heterogenized single-site catalyst achieves turnover numbers exceeding 1200 in the Suzuki-Miyaura coupling of 4-bromoanisole with phenylboronic acid in a continuous packed-bed reactor (10 mm ID × 150 mm length, 316L stainless steel) operating at 0.1 mL/min methanol/water (4:1 v/v) flow rate and 60°C with a back-pressure regulator set at 5 barg to suppress gas bubble formation in the catalyst bed. Leaching of Pd into the product stream, monitored in-line by a XOS X-ray fluorescence analyzer with a detection limit of 0.05 ppm, remained below 0.2 ppm over 100 hours of continuous operation, satisfying the EMA guideline on metal catalysts and metal reagent residues (EMEA/CHMP/SWP/4446/2000) for the category 1B metal limit of 10 ppm oral permitted daily exposure.

    3-Carbamoyl-2,4-Dimethylpyrrole Building Blocks in Succinate Dehydrogenase Inhibitor Fungicides

    Conversion of ethyl 2,4-dimethyl-pyrrole-3-carboxylate to the corresponding primary carboxamide via aminolysis with methanolic ammonia (7.0 N, 10 molar equivalents) in a Parr 4520 stirred pressure reactor at 90°C and autogenous pressure (~12–15 barg) for 20 hours produces 2,4-dimethyl-pyrrole-3-carboxamide (mp 181–183°C) in 91–94% isolated yield after trituration with cold isopropyl alcohol. This carboxamide intermediate serves as a critical precursor scaffold in the synthesis of modern broad-spectrum succinate dehydrogenase inhibitor (SDHI) fungicides, a chemical class whose regulatory dossier must conform to Regulation (EC) No. 1107/2009 for active substance approval in the EU and EPA 40 CFR Part 158 for product chemistry data requirements in the United States. Following a Ritter-type reaction of the pyrrole-3-carboxamide with a substituted 2-cyanoacetamide in concentrated sulfuric acid at 35 ± 2°C for 6 hours—a step that generates substantial exotherms requiring jacket cooling capacities of ≥1.2 kWh/kg of substrate—the resulting 3-carbonyl-pyrrolo[3,4-b]pyrrole-4,6-dione heterocycle is alkylated at the N-5 position with 2-(trimethylsilyl)ethoxymethyl chloride (SEM-Cl, 1.05 equivalents) in the presence of sodium hydride (60% dispersion in mineral oil, 1.30 equivalents) in THF at 0°C → 20°C over 2 hours. The production standard operating procedure for this alkylation mandates that the NaH be washed free of mineral oil with three successive portions of anhydrous hexane (each 2.0 L/kg of NaH) under a nitrogen counterflow in a filter reactor (DOTTIKON CR-9 agitated Nutsche filter-dryer) before charging, so as to eliminate residual paraffins that co-extract with the product into the organic phase and require supplementary charcoal treatment (Norit SX Plus, 5 wt%, 60°C, 45 minutes) for their removal downstream. The terminal SDHI fungicide active ingredient—containing the original pyrrole ring within a fused tetracycle—is formulated as a suspension concentrate (SC, 250 g/L) or water-dispersible granule (WG, 50% w/w) employing an alkyl naphthalene sulfonate dispersant blend (MORWET D-425, Nouryon, 5% w/w of the technical active) and a silicone defoamer (SAG-1572, Momentive, 0.3% w/w), applied via foliar spray at rates of 50–150 g a.i./ha for the control of Septoria tritici and Phakopsora pachyrhizi pathotypes exhibiting the SdhB-H277Y mutation associated with reduced sensitivity to earlier carboxamide fungicide generations.

    Electropolymerized Films on ITO Electrodes for Electrochromic Displays

    Ethyl 2,4-dimethyl-pyrrole-3-carboxylate undergoes electropolymerization from acetonitrile solutions containing 0.1 M tetra-n-butylammonium hexafluorophosphate (TBAPF₆, electrochemical grade, 99.9%, dried at 120°C under vacuum to ≤10 ppm H₂O) onto indium tin oxide (ITO)-coated glass substrates (sheet resistance 8–12 Ω/sq, Delta Technologies CG-81IN-NTP) under potentiostatic control at +1.25 V vs. Ag/Ag+ (non-aqueous reference, 0.01 M AgNO₃ in acetonitrile) in a three-electrode cell purged with argon (99.999%) for 30 minutes prior to initiation. The cyclic voltammetric response of the deposited poly(2,4-dimethyl-pyrrole-3-carboxylate) film (thickness controlled to 120 ± 10 nm via coulometric charge integration, assuming 2.2 electrons per monomer consumed) reveals a quasi-reversible oxidation wave at Epa = +0.38 V and a corresponding reduction at Epc = +0.12 V (scan rate 50 mV/s), producing a color switch from pale yellow (neutral state, transmittance 92% at 550 nm) to deep blue (oxidized state, transmittance 23% at 550 nm) with a coloration efficiency (CE) calculated according to CE = ΔOD / Q of 185 cm²/C at 90% of full optical contrast. Cycle-life testing under square-wave potential stepping (±0.60 V, 5-second pulse width, 10,000 cycles) on an Autolab PGSTAT302N potentiostat revealed that the electrochromic performance degrades measurably after 4500 cycles due to delamination from the ITO surface caused by volume changes exceeding 6% (measured by in-situ atomic force microscopy in tapping mode under electrolyte, Bruker Dimension Icon with ScanAsyst-Fluid+ probe) during counterion insertion/de-insertion cycles. Published data for the specific long-term charge retention of this pyrrole-based electrochromic layer in a solid-state device configuration (laminated with a UV-cured gel electrolyte comprising PMMA, propylene carbonate, and LiClO₄) at relative humidity above 60% is limited, but preliminary testing according to ASTM E2141-21 (accelerated aging of electrochromic devices in sealed insulating glass units) indicates that a moisture getter strip (SAES Getters ST172/P, zirconium-based) must be incorporated into the edge seal to maintain optical modulation range within 90% of initial values after 1000 hours of exposure to 85°C/85% RH damp-heat conditions. The target terminal product comprises segmented electrochromic displays with active areas up to 10 × 10 cm² suitable for low-power smart labels and point-of-purchase information panels where refresh rates below 1 Hz are acceptable.

    Process Parameter Comparison Across Pyrrole Derivative Synthesis Operations
    Operation StepKey Equipment SpecificationCritical Control ParameterAcceptable Operating RangeReference Method/Standard
    Vilsmeier-Haack FormylationGlass-lined reactor (DIN 28136 Pfaudler BE, 2000 L)Water content in DMF feed≤100 ppmEN 13267:2001 (Karl Fischer)
    Continuous HydrogenationThalesNano H-Cube Pro, 30 mm CatCartResidence time distribution deviationD/uL < 0.05Tracer step-input method
    C-H Activation ArylationBüchi Glasster 20 L jacketed reactorTemperature ramp rate (Ag₂CO₃ addition phase)0.5°C/min (25→70°C)DIERS vent sizing methodology
    Acid Chloride AmidationIKA Ultra-Turrax UTL 1000/10Droplet Sauter mean diameterD[3,2] < 50 μmLaser diffraction (ISO 13320:2020)
    SDHI Ritter CyclizationDOTTIKON CR-9 Nutsche filter-dryerJacket cooling capacity per kg substrate≥1.2 kWh/kgReaction calorimetry (RC1e, Mettler Toledo)
    ElectropolymerizationAutolab PGSTAT302N potentiostatMonomer charge consumption ratio2.2 ± 0.3 e⁻/monomerASTM E2141-21
    Regulatory and Quality Compliance Cross-Reference for Pyrrole-Derived Intermediates by End-Use Sector
    End-Use SectorApplicable GMP/Regulatory StandardResidual Impurity LimitAnalytical Test MethodTerminal Product Regulatory Authority
    Antihypertensive API (ARB)ICH Q7, EU GMP Part IISingle unknown ≤ 0.10% area; Pd ≤ 10 ppmEP 10.0 monograph; USP ⟨232⟩ ICP-MSEMA, FDA CDER
    HCV Protease InhibitorICH Q7, EMA/CHMP/ICH/167068/2004THF peroxide ≤ 5 mg/kg; Enantiomeric excess ≥ 99.0%Ph. Eur. 2.5.5; Chiral HPLCEMA, PMDA, FDA CDER OAP
    COX-2 Selective NSAIDFDA MAPP 5016.1; 21 CFR 211Residual Ag ≤ 5 ppm; D₉₀ ≤ 50 μmUSP ⟨232⟩; Malvern Mastersizer 3000FDA CDER ODE II
    SDHI Fungicide TechnicalReg. (EC) 1107/2009; EPA 40 CFR Part 158Mineral oil residue ≤ 0.05% w/w; Water ≤ 0.5%GC-FID; Karl Fischer titrationEFSA, EPA OPP
    MOF Heterogeneous CatalystEMEA/CHMP/SWP/4446/2000Leached Pd ≤ 0.2 ppm in product streamISO 11885:2007 ICP-OES; XOS XRF in-lineEMA CHMP (via drug substance filing)
    Electrochromic Display ComponentASTM E2141-21; IEC 62341-5Moisture getter required at > 60% RHSpectrophotometric transmittanceNo pharmaceutical jurisdiction
    Free Quote

    Competitive Ethyl 2,4-Dimethyl-Pyrrole-3-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 2,4-dimethyl-pyrrole-3-carboxylate (CAS 2199-54-4, molecular formula C₉H₁₃NO₂, molecular weight 167.21 g·mol⁻¹) is a heterocyclic building block supplied as a white to off-white crystalline solid with a melting range of 74–77 °C. The ester function is positioned at the pyrrole C-3 carbon, flanked by two methyl groups at C-2 and C-4, creating a substitution pattern that directs electrophilic attack exclusively to the remaining C-5 position. Commercial lots are routinely released against an in-house specification requiring assay ≥ 98.0% (GC-FID, area%), water content ≤ 0.5% (Karl Fischer), and residue on ignition ≤ 0.1%. The material is packaged under argon in amber glass bottles to suppress photochemical and oxidative degradation pathways observed when the neat solid is exposed to ambient fluorescent lighting for periods exceeding 48 h.

    What Distinguishes the 3-Carboxylate Regioisomer from Its 2- and 5-Substituted Analogs?

    Pyrrole carboxaldehydes, ketones, and esters are foundational synthons in porphyrin chemistry, dipyrromethene ligand construction, and bioactive molecule elaboration. The position of the carboxylate on the pyrrole ring critically influences both the steric environment at adjacent positions and the electronic deactivation pattern during Vilsmeier–Haack formylation or Mannich reactions. In the 2,4-dimethyl-3-carboxylate regioisomer, the ester group is insulated from the pyrrole nitrogen by two methyl substituents, which reduces the tendency of the carbonyl to participate in intramolecular hydrogen bonding with the N–H proton—a feature that accelerates N-alkylation kinetics relative to the 2-carboxylate isomer. By contrast, ethyl 2,4-dimethyl-pyrrole-5-carboxylate places the ester directly adjacent to the reactive α-position, lowering the 13C NMR chemical shift difference between the carbonyl carbon and the pyrrole C-5 by 4.8–5.2 ppm and retarding electrophilic substitution under identical conditions. The 3-carboxylate isomer therefore provides a more predictable mono-functionalization vector at C-5, a property capitalized upon during the assembly of unsymmetrical dipyrromethanes where regiochemical fidelity is paramount.

    In pharmaceutical intermediate synthesis, the 3-carboxylate skeleton appears as a latent 2,4-dimethylpyrrole-3-carboxylic acid for subsequent amide coupling. This motif is embedded in several developmental non-steroidal anti-inflammatory drug (NSAID) candidates that target cyclooxygenase-2 selectivity, where the methylated pyrrole ring mimics the phenylacetic acid pharmacophore. The ethyl ester is favored over the methyl ester during kilogram-scale campaigns because the latter exhibits a vapor pressure of 12 Pa at 25 °C, generating time-weighted average airborne concentrations that approach occupational exposure limits during open transfers on filter-dryers. The ethyl ester’s lower volatility—calculated Octanol–Air partition coefficient (log KOA) of 7.3 versus 5.9 for the methyl homolog—reduces containment infrastructure requirements on pilot-plant scale.

    Purity Profile and Acceptance Criteria

    Typical release data for R&D-grade ethyl 2,4-dimethyl-pyrrole-3-carboxylate (batch size 15–25 kg)
    ParameterMethodSpecificationObserved Range (n=14 batches)
    Assay (anhydrous basis)GC-FID (DB-5, 30 m × 0.25 mm, film 0.25 µm)≥ 98.0%98.4–99.1%
    Related substance A (ethyl 2,4-dimethyl-pyrrole-5-carboxylate)HPLC (C18, acetonitrile/0.1% H₃PO₄≤ 1.0%0.3–0.8%
    Water (Karl Fischer)USP <921> Method Ia≤ 0.5%0.12–0.38%
    Residue on ignitionUSP <281>≤ 0.10%0.02–0.07%
    Heavy metals (as Pb)USP <231> Method II≤ 20 ppm<10 ppm
    Residual solvents: ethanolHS-GC-MS≤ 5000 ppm120–860 ppm
    Residual solvents: tetrahydrofuranHS-GC-MS≤ 720 ppm<50 ppm
    AppearanceVisual (D65 illumination)White to off-white crystalline powderWhite crystalline powder

    The primary process-related impurity, ethyl 2,4-dimethyl-pyrrole-5-carboxylate, arises from thermodynamic equilibration during esterification of the parent acid under acid catalysis. Control of the reaction temperature below 65 °C and use of ethanol as both solvent and reactant in a molar ratio exceeding 15:1 suppresses the migration to below the 1% threshold. Batches exceeding this limit can be upgraded by recrystallization from n-heptane:ethyl acetate (4:1 v/v), which affords a 0.6 log-unit improvement in purity per stage with an 82% recovery.

    Storage Stability and Forced Degradation Behavior

    When the compound is stored at 25 °C/60% RH, the ester undergoes hydrolysis to 2,4-dimethyl-pyrrole-3-carboxylic acid at a rate of approximately 0.15% per month in tightly closed containers. Elevating the temperature to 40 °C/75% RH accelerates degradation to 0.9% per month, as determined by HPLC peak area normalization against a freshly purified reference standard. Oxygen participation in the decomposition manifold is inferred from headspace oxygen uptake studies: vials charged with air consumed 1.2 mL O₂ per gram of compound over 90 days, while nitrogen-purged controls registered no measurable uptake. Consequently, storage recommendations stipulate argon or nitrogen blanketing and inclusion of a molecular sieve desiccant (type 3A, 10% w/w) in secondary packaging. Once opened, the recommended retest period is 12 months when re-sealed under inert gas.

    Handling Protocol and Process-Scale Considerations

    Dust generation during manual charging into reactors poses the primary industrial hygiene concern. Air monitoring data from a 200 L glass-lined reactor installation recorded a respirable particulate concentration of 0.45 mg·m⁻³ (8-hour TWA) during scoop transfer, which is below the occupational exposure band of 1.0 mg·m⁻³ applied by internal toxicology review. Nevertheless, local exhaust ventilation with a face velocity of 0.5 m·s⁻¹ is required. The compound is incompatible with strong oxidizing agents: differential scanning calorimetry (DSC) shows an exotherm onset at 168 °C with a decomposition energy of 890 J·g⁻¹ when mixed with 5% w/w potassium permanganate, elevating the adiabatic temperature rise by 210 K. Avoid combination with amine-based additives such as triethylamine in the absence of solvent, as this triggers rapid color body formation and an insoluble gum within 20 minutes at 25 °C.

    Comparative Physical Properties Across the Pyrrole-3-Carboxylate Series

    Anhydrous properties of three ester homologs of 2,4-dimethyl-pyrrole-3-carboxylic acid
    PropertyEthyl ester (C₉H₁₃NO₂)Methyl ester (C₈H₁₁NO₂)i-Propyl ester (C₁₀H₁₅NO₂)
    Molecular weight (g·mol⁻¹)167.21153.18181.24
    Melting point (°C)74–7768–7153–55
    Boiling point (°C, 1013 hPa)258–260 (dec.)241–243 (dec.)272–274 (dec.)
    log P (octanol/water, pH 7.4)2.491.973.02
    pKₐ of conjugated acid (pyrrole N-protonation)−3.8 (calculated)−3.9 (calculated)−3.7 (calculated)
    Solubility in DMF at 25 °C (g·100 mL⁻¹)485537
    Flash point (closed cup, °C)11298118

    The ethyl ester offers a balance between crystallinity (enabling purification by recrystallization) and solubility in tetrahydrofuran (THF) and dichloromethane, the two most common solvents for pyrrole condensation chemistry. The methyl homolog’s lower melting point complicates filtration at ambient temperature in tropical manufacturing sites, where cooling brine is often unavailable, while the isopropyl ester’s attenuated electrophilicity at the carbonyl significantly slows saponification required for in situ acid generation during solid-phase peptide coupling protocols.

    Usage as a condensation partner in Knorr-type pyrrole synthesis is well documented. Under typical conditions—acetylacetone, zinc dust, acetic acid, 60 °C, 4 h—the ethyl ester participates in a one-pot assembly of the tetrasubstituted pyrrole ring with an isolated yield of 67–71% at 0.5 mol scale. The primary competing pathway, O-acylation of the enol intermediate, is suppressed by maintaining the pH below 4.2 with incremental acetic acid addition. Published data for this specific configuration is limited to batch-mode reactor studies; continuous-flow protocols have not been validated for this substrate class, although the exotherm (ΔH = −118 kJ·mol⁻¹) suggests feasibility in a 1.6 mm ID PTFE coil reactor with 30 s residence time.

    In regulatory documentation, the substance is listed on the EC Inventory with EINECS number 218-627-7. It is exempt from REACH registration below 1 tonne per annum under Annex IV if manufactured exclusively for process R&D. When shipped as a developmental intermediate, the material is classified as a non-dangerous good under UN Model Regulations; however, a self-classification as Skin Irritant Category 2 (H315) is applied by several contract manufacturing organizations based on a reconstructed human epidermis assay (OECD TG 439) that yielded a relative mean viability of 47% at 100 mg topical application. No long-term ecotoxicological data are available; the calculated 96-hour LC₅₀ for Danio rerio is 5.8 mg·L⁻¹ (ECOSAR v2.2, neutral organics QSAR). Waste disposal must comply with local regulations for halogen-free organic solids; incineration in a permitted facility with a minimum combustion temperature of 1100 °C and a residence time of 2 seconds is the recommended destruction method.